Risk Factors Associated with Advanced Liver Disease in Cystic Fibrosis Patients Identified

New study can help identify a group of children and adolescents with cystic fibrosis who are at a higher risk of developing advanced liver disease.

Children's Hospital Colorado (Children's Colorado) pediatric gastroenterologist, Michael Narkewicz, MD, recently shared results of the Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in Cystic Fibrosis (PUSH), which sought to determine if liver ultrasounds could identify children and adolescents with cystic fibrosis who are at greater risk of developing advanced liver disease.

Cystic Fibrosis - Symptoms, Causes, Diagnosis, Treatment, Support Groups
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure

‘New study identifies the factors that are associated with a higher risk of developing advanced liver disease in cystic fibrosis patients.’
Read More..

Tweet it Now

The Cystic Fibrosis Liver Disease Network PUSH study is a multicenter prospective observational clinical trial that tested the hypothesis that a heterogeneous pattern (i.e., not totally uniform) on a liver ultrasound predicts the subsequent development of cirrhosis, late advanced stage of scarring (fibrosis) of the liver. Dr. Narkewicz presented the study results at the North American Cystic Fibrosis Conference after four years of research that was funded by the Cystic Fibrosis Foundation and The National Institute of Diabetes and Digestive and Kidney Diseases.

Advanced liver disease is a complication that affects about seven percent of all individuals with cystic fibrosis and is the third leading cause of death in cystic fibrosis. Primarily, this is a complication that affects children and adolescents, with 10 years of age marking the average age of diagnosis. To date, there is no test that can identify children at risk for developing advanced liver disease.

The team enrolled 744 children and adolescents with cystic fibrosis who did not have known advanced liver disease. All subjects underwent a research ultrasound of the liver that was scored by four independent study radiologists. Those with a heterogeneous ultrasound pattern of the liver and two matched controls with a normal pattern received follow-up ultrasounds every other year.

Simple Noninvasive Test can Help Personalize Cystic Fibrosis Treatment
Personalized medications can now be developed by a simple non invasive test for cystic fibrosis found a new study

At the end of four years of follow-up, the team found that individuals with heterogeneous ultrasound patterns had a 9.3 times increased risk of developing advanced liver disease. 25 percent of the individuals with a heterogeneous pattern developed advanced liver disease within four years.

"This is the first study to identify a tool to classify a group of children and adolescents with cystic fibrosis who are at high risk for developing advanced liver disease," said Dr. Narkewicz.

Cystic Fibrosis Patients With Specific Mutations To Benefit From New Drug
A new combination drug for cystic fibrosis has been approved by the USFDA in people ages 12 and older that can treat the underlying cause of the disease.

"This is an important discovery that provides an opportunity to continue testing interventions that might slow or stop that progression. This also might have relevance for screening in routine clinical care."

Dr. Narkewicz and his team are further refining the prediction model using lab tests and other innovative diagnostic tests that are part of the ongoing network studies. This sets up the possibility of designing trials for interventions to try to prevent the development of advanced liver disease in more cystic fibrosis patients.

Cystic Fibrosis Impacts Growth in the Womb
Babies with cystic fibrosis (CF) are born weighing less than babies without the condition, even allowing that they are more likely to be born prematurely.

Source-Eurekalert